BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8891830)

  • 1. Vitiligo associated with metastatic malignant melanoma.
    Cavallari V; Cannavò SP; Ussia AF; Moretti G; Albanese A
    Int J Dermatol; 1996 Oct; 35(10):738-40. PubMed ID: 8891830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vitiliginous depigmentation in patients suffering from malignant melanoma].
    Frenk E
    Dermatologica; 1969; 139(1):84-91. PubMed ID: 5810156
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
    Nishitani N; Bito T; Ikeda T; Tokura Y; Nishigori C
    J Dermatol; 2010 Aug; 37(8):770-2. PubMed ID: 20649729
    [No Abstract]   [Full Text] [Related]  

  • 4. Metastatic melanoma and vitiligo: a case report.
    Buljan M; Situm M; Lugović L; Vucić M
    Acta Dermatovenerol Croat; 2006; 14(2):100-3. PubMed ID: 16859616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depigmentation: its significance in patients with melanoma.
    Barnes L; Nordlund JJ
    Clin Dermatol; 1989; 7(2):66-73. PubMed ID: 2667742
    [No Abstract]   [Full Text] [Related]  

  • 6. Vitiligo associated with malignant melanoma and lupus erythematosus.
    Gül U; Kiliç A; Tulunay O; Kaygusuz G
    J Dermatol; 2007 Feb; 34(2):142-5. PubMed ID: 17239155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant melanoma, leukoderma and vitiligo].
    Kraus L; Landthaler M
    Z Hautkr; 1980 Feb; 55(4):218-31. PubMed ID: 6996365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant melanoma and vitiligo.
    Balabanov K; Andreev VC; Tchernozemski I
    Dermatologica; 1969; 139(3):211-9. PubMed ID: 5808472
    [No Abstract]   [Full Text] [Related]  

  • 9. Adult-onset leukoderma and malignant melanoma.
    Gross DJ; Singer PG; Schosser RH
    Arch Dermatol; 1990 Sep; 126(9):1240-1. PubMed ID: 2396849
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypopigmentation, vitiligo, and melanoma. New data, more enigmas.
    Nordlund JJ
    Arch Dermatol; 1987 Aug; 123(8):1005-8. PubMed ID: 3631979
    [No Abstract]   [Full Text] [Related]  

  • 11. Images in clinical medicine. Vitiligo and cutaneous melanoma.
    Redondo P; Del Olmo J
    N Engl J Med; 2008 Jul; 359(3):e3. PubMed ID: 18635425
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adhesive tape induced depigmentation. An ultrastructural study and comparison with vitiligo and vitiliginous depigmentation associated with melanoma (author's transl)].
    Frenk E; Kocsis M
    Dermatologica; 1974; 148(5):276-84. PubMed ID: 4420330
    [No Abstract]   [Full Text] [Related]  

  • 13. Coexisting malignant melanoma and vitiligo in a Nigerian.
    Alabi GO; Falope ZF; Lekwauwa UG
    West Afr J Med; 1991; 10(1):443-6. PubMed ID: 2069894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iritis in patients with cutaneous melanoma and vitiligo.
    Albert DM; Sober AJ; Fitzpatrick TB
    Arch Ophthalmol; 1978 Nov; 96(11):2081-4. PubMed ID: 718499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
    Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
    J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypopigmented malignant melanoma simulating vitiligo.
    Kossard S; Commens C
    J Am Acad Dermatol; 1990 May; 22(5 Pt 1):840-2. PubMed ID: 2347968
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavior of pigment cells on lesions of the pigmented venus with vitiligo.
    Hamada T; Sakurane HF; Saito T
    J Dermatol; 1979 Jun; 6(3):143-52. PubMed ID: 393743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitiligo and malignant melanoma (author's transl)].
    Hamm G; Fiedler H
    Dermatol Monatsschr; 1979 Dec; 165(12):838-42. PubMed ID: 546664
    [No Abstract]   [Full Text] [Related]  

  • 19. Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.
    Yee C; Thompson JA; Roche P; Byrd DR; Lee PP; Piepkorn M; Kenyon K; Davis MM; Riddell SR; Greenberg PD
    J Exp Med; 2000 Dec; 192(11):1637-44. PubMed ID: 11104805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitiligo as an undesired side-effect in the management of melanoma. A contribution to experimental vitiligo research].
    Friederich HC
    Arch Klin Exp Dermatol; 1967; 229(2):223-30. PubMed ID: 5588112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.